Soria JC - Search Results

1

Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC.

Facchinetti F, Marabelle A, Rossi G, Soria JC, Besse B, Tiseo M. Facchinetti F, et al. Among authors: soria jc. J Thorac Oncol. 2016 Nov;11(11):1819-1836. doi: 10.1016/j.jtho.2016.05.027. Epub 2016 Jun 8. J Thorac Oncol. 2016. PMID: 27288978 Free article. Review.

2

Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer.

Besse B, Candé C, Spano JP, Martin A, Khayat D, Le Chevalier T, Tursz T, Sabatier L, Soria JC, Kroemer G. Besse B, et al. Among authors: soria jc. Clin Cancer Res. 2004 Sep 1;10(17):5665-9. doi: 10.1158/1078-0432.CCR-04-0415. Clin Cancer Res. 2004. PMID: 15355891

3

[Predicting response to Iressa: unexpected mechanism].

Besse B, Le Chevalier T, Soria JC. Besse B, et al. Among authors: soria jc. Med Sci (Paris). 2004 Aug-Sep;20(8-9):750-1. doi: 10.1051/medsci/2004208-9750. Med Sci (Paris). 2004. PMID: 15361339 Free article. French. No abstract available.

4

Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.

Erman M, Grunenwald D, Penault-Llorca F, Grenier J, Besse B, Validire P, Morat L, Girard P, Le Chevalier T, Sabatier L, Soria JC. Erman M, et al. Among authors: soria jc. Lung Cancer. 2005 Mar;47(3):315-23. doi: 10.1016/j.lungcan.2004.08.015. Lung Cancer. 2005. PMID: 15713515

5

Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy.

Besse B, Soria JC, Le Chevalier T. Besse B, et al. Among authors: soria jc. Ann Oncol. 2005 Jul;16(7):997-8. doi: 10.1093/annonc/mdi231. Epub 2005 Jun 9. Ann Oncol. 2005. PMID: 15946975 Free article. No abstract available.

6

[EGFR-targeted therapies: what's new?].

Vignot S, Besse B, Soria JC, Milano G, Spano JP. Vignot S, et al. Among authors: soria jc. Bull Cancer. 2006 Jan;93(1):13-8. Bull Cancer. 2006. PMID: 16455501 Free article. Review. French.

7

Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.

Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S. Grenier J, et al. Among authors: soria jc. Anticancer Res. 2007 Jan-Feb;27(1B):547-55. Anticancer Res. 2007. PMID: 17348440 Free article.

8

[Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient].

Besse B, Soria JC. Besse B, et al. Among authors: soria jc. Rev Prat. 2007 Feb 28;57(4):429-40; quiz 440. Rev Prat. 2007. PMID: 17455746 Review. French. No abstract available.

9

Targeted therapies in lung cancer.

Besse B, Ropert S, Soria JC. Besse B, et al. Among authors: soria jc. Ann Oncol. 2007 Jul;18 Suppl 9:ix135-42. doi: 10.1093/annonc/mdm308. Ann Oncol. 2007. PMID: 17631566 Free article. Review. No abstract available.

10

Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.

Saintigny P, Besse B, Callard P, Vergnaud AC, Czernichow S, Colombat M, Girard P, Validire P, Breau JL, Bernaudin JF, Soria JC. Saintigny P, et al. Among authors: soria jc. Clin Cancer Res. 2007 Aug 15;13(16):4825-31. doi: 10.1158/1078-0432.CCR-06-3061. Clin Cancer Res. 2007. PMID: 17699861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters